Discover how our integrated approach to analysing world Healthcare markets gives you the insight you need to inform critical decisions.


GSK To Strengthen R&D Commitment Through Strategic Partnerships

The demand for chronic respiratory treatments in China will continue to rise. Within this disease area, chronic obstructive pulmonary disease is dominant and will be a key area of unmet medical need, as factors such as air pollution remain entrenched. As a consequence, pharmaceutical firms will continue to build their presence in China, aligning themselves with the government's push to develop the healthcare sector and transforming the traditional model of diagnosis and treatment.




The Year Ahead: Pharma & Healthcare in 2017


Kaushal Shah

Head of Pharmaceuticals and Healthcare Research
Pharmaceuticals & Healthcare | London

Jamie Davies

Head of Pharmaceuticals, Medical Devices and Healthcare Research
Pharmaceuticals & Healthcare | London


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.